A FOLLOW-UP TO FRIDAY'S NEWS LETTER ON MORTALITY AND INOCULANT RELATED MYOCARDITIS

CDC Gets it Wrong Again

Two days ago I wrote about a recent study from the UK that showed that the mRNA inoculants of Pfizer and Moderna are related to mortality from myo/pericarditis. Today, I want to draw your attention to an article published in Pharmacological Drug Safety on April 16, 2022 which compared two methods of assigning myo/pericarditis to the mRNA inoculant.

The first method is by examination of the data in CDC’s Vaccine Safety Data Link which “…is a collaborative project between CDC’s Immunization Safety Office and nine health care organizations. The VSD started in 1990 and continues today in order to monitor safety of vaccines and conduct studies about rare and serious adverse events following immunization.”

The second method used by Sharff et al., Kaiser Permanente Northwest (KPNW), examined insurance records to establish a chohort of patients who were 12 -39 years who had been diagnosed with myo/pericarditis.

There are several things that need to be mentioned . First, KPNW is one of the nine health care organizations that contributes data to CDC’s Vaccine Safety Data link.

Second, there must have been a “disagreement” between the CDC Safety Data Link staff and those at KPNW which led to the paper by Sharff et al.

The nature of that “disagreement lies in how CDC and KPNW counted mRNA inoculant related myo/pericarditis cases:

The encounter methodology identified 14 distinct patients who met the confirmed or probable CDC case definition for acute myocarditis or pericarditis with an onset within 21 days of receipt of COVID‐19 vaccination. When we extended the search for relevant diagnoses to 30 days since vaccination, we identified two additional patients (for a total of 16 patients) who met the case definition for acute myocarditis or pericarditis, but those patients had been misdiagnosed at the time of their original presentation. Three of these patients had an ICD‐10‐CM code of I51.4 “Myocarditis, Unspecified;” that code was omitted by the VSD algorithm (in the late fall of 2021). The VSD methodology identified 11 patients who met the CDC case definition for acute myocarditis or pericarditis. Seven (64%) of the 11 patients had initial care for myopericarditis outside of a KPNW facility and their diagnosis could not be ascertained by the VSD methodology until claims were submitted (median delay of 33 days; range of 12–195 days). Among those who received a second dose of vaccine (n = 146 785), we estimated a risk as 95.4 cases of myopericarditis per million second doses administered (95% CI, 52.1–160.0). (Sharff et al.)

Sharff et al. concluded: We identified additional valid cases of myopericarditis following an mRNA vaccination that would be missed by the VSD's search algorithm, which depends on select hospital discharge diagnosis codes. The true incidence of myopericarditis is markedly higher than the incidence reported to US advisory committees in the fall of 2021. The VSD should validate its search algorithm to improve its sensitivity for myopericarditis.

In other words, CDC was told the they were under reporting the number of inoculant related cases of my-pericarditis AND they failed to tell this to their own Advisory Committee on Immunization Practices. It is hard to give good advice if the people you’re advising don’t give you all the information.

Let’s connect the dots a little bit. In 2010 Robert Lazarus submitted his final grant report (Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS) to the CDC. In his report Lazarus and his colleagues concluded that VAERS was grossly under reported by a factor of 100. The suggestions made by Lazarus to “fix” VAERS were ignored by CDC and thus VAERS remains grossly under reported.

Now, in 2022, Sharff et al. from KPNW — a CDC partner in building CDC’s Safety Data Link network has told CDC that their algorithm for identifying myo/pericarditis cases directly related to the mRNA inoculant is flawed and that “The true incidence of myopericarditis is markedly higher than he incidence reported to the US Advisory committees in the fall of 2021.”

Twice the CDC has been told by people they have hired or partnered with that their methodology for tracking vaccine related adverse events is deeply flawed; once in 2010 and now in 2022.

The net result is that we have no idea what the true rate of mRNA inoculant related mypericarditis is and neither does CDC. Meanwhile the CDC continues to insist that:

“Myocarditis and pericarditis have rarely been reported.”

In 2010 CDC ignored Lazarus. It remains to be seen whether they will ignore Sharff and the data presented by Patone et al. which provides proof of mRNA inoculant related myopericarditis mortality.

You can’t find what you’re not looking for. Clearly the CDC is understating the true incidence of myopericarditis among the nations people. This is particularly true among our children who they continue to insist should be inoculated even though they have little or no risk of contracting COVID-19 or dying from it.

Why?

Their malice may be concealed by deception, but their wickedness will be exposed in the assembly. Proverbs 26:26

Union, Kentucky

18 September 2022